SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]:
SEC Accession No. 0001193125-20-143099
Filing Date
2020-05-15
Accepted
2020-05-14 21:55:33
Documents
3
Effectiveness Date
2020-05-15

Document Format Files

Seq Description Document Type Size
1 POS EX d861503dposex.htm POS EX 33107
2 EX-5.1 d861503dex51.htm EX-5.1 8227
3 GRAPHIC g844461g0508121746132.jpg GRAPHIC 2538
  Complete submission text file 0001193125-20-143099.txt   46031
Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS EX | Act: 33 | File No.: 333-238194 | Film No.: 20880270
SIC: 2836 Biological Products, (No Diagnostic Substances)